Glucose supply and insulin demand dynamics of antidiabetic agents.
Monte
Scott V
SV
CPL Associates, LLC, Amherst, New York 14226, USA. smonte@cplassociates.com
Schentag
Jerome J
JJ
Adelman
Martin H
MH
Paladino
Joseph A
JA
D017485:1-Deoxynojirimycin / Q000031:analogs & derivatives / Q000627:therapeutic use; D020909:Acarbose / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control; D048909:Diabetes Complications / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000453:epidemiology / Q000517:prevention & control; D004040:Dietary Carbohydrates; D002149:Energy Intake / Q000187:drug effects; D005500:Follow-Up Studies; D005943:Gluconeogenesis / Q000187:drug effects / Q000502:physiology; D005947:Glucose / Q000378:metabolism*; D006442:Glycated Hemoglobin / Q000187:drug effects / Q000378:metabolism; D006331:Heart Diseases / Q000453:epidemiology / Q000517:prevention & control; D006706:Homeostasis; D006801:Humans; D007004:Hypoglycemic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007328:Insulin / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007408:Intestinal Absorption / Q000187:drug effects; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008687:Metformin / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000453:epidemiology / Q000517:prevention & control; D045162:Thiazolidinediones / Q000627:therapeutic use
D017485:1-Deoxynojirimycin; D020909:Acarbose; D004040:Dietary Carbohydrates; D005947:Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D008687:Metformin; D045162:Thiazolidinediones; C045621:miglitol